Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2020-00573 | Registry Identifier | CTRP (Clinical Trial Reporting Program) | |
| 2012-0362 | Other Identifier | M D Anderson Cancer Center | |
| R41CA168107 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Cancer Institute (NCI) | NIH |
Not provided
Not provided
Not provided
Not provided
This trial collects feedback from patients to develop a video game in improving the outcomes in stem cell transplant survivors. A video game may help to improve health behaviors for leukemia or lymphoma patients after stem cell transplant.
PRIMARY OBJECTIVES:
I. Develop a prototype intervention electronic game that implements a baseline testable feature set, including features for social networking within a virtual game space, managing an intermittent mediated reward cycle, goal setting and tracking, and collaborative problem solving.
II. Evaluate the technical merit, feasibility, user perception and acceptance of the prototype system with adolescents and young adults (AYAs) allogeneic hematopoietic stem cell transplantation (HSCTs) patients in recovery.
III. Based on the results of the prototype evaluation, enhance and complete development of the Stempowerment on-line intervention.
IV. This is a single arm study with no comparison group; therefore, the purpose is to evaluate the impact of the Stempowerment intervention on
OUTLINE: Patients are assigned to 1 of 2 groups.
GROUP I: Patients attend a focus group for up to 1.5 hours and provide feedback on design elements, specific desirable features, and preferences for the initial prototype.
GROUP II: Patients have access to the game for 3 weeks and then provide feedback on problems or questions regarding the use of the prototype.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group I (focus group) | Patients attend a focus group for up to 1.5 hours and provide feedback on design elements, specific desirable features, and preferences for the initial prototype. |
| |
| Group II (access to the game) | Patients have access to the game for 3 weeks and then provide feedback on problems or questions regarding the use of the prototype. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Focus Group | Behavioral | Attend a focus group |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility of electronic game intervention | Primary feasibility benchmark based on responses to questions regarding users' perceptions of the technology. If 75% of respondents have a mean score reflecting positive responses (e.g., strongly agree or agree) to each of the 7 constructs related to users' perceptions, as described above, then feasibility benchmark met. Responses to open-ended questions analyzed qualitatively using Atlas.ti software. Responses to individual questions evaluated to look for common themes, and findings used to inform future development of the prototype. | 4 weeks |
Not provided
Not provided
Inclusion Criteria:
Phase I
The target population for this study will consist of:
Phase II
The target population for this study will consist of:
Exclusion Criteria:
Phase I
The target population will be excluded if:
Phase II
The target population will be excluded if:
Not provided
Not provided
Patients with leukemia or lymphoma
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Susan Peterson, MPH,PhD | Contact | 713-792-8267 | speterso@mdanderson.org |
| Name | Affiliation | Role |
|---|---|---|
| Susan K Peterson | M.D. Anderson Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| M D Anderson Cancer Center | Recruiting | Houston | Texas | 77030 | United States |
Not provided
| Label | URL |
|---|---|
| MD Anderson Cancer Center | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D007938 | Leukemia |
| D008223 | Lymphoma |
| ID | Term |
|---|---|
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D006402 | Hematologic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D017144 | Focus Groups |
| D007407 | Interviews as Topic |
| ID | Term |
|---|---|
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D008919 | Investigative Techniques |
| D017531 | Health Care Evaluation Mechanisms |
Not provided
Not provided
Not provided
Not provided
Not provided
| Internet-Based Intervention |
| Other |
Have access to the game |
|
| Interview | Behavioral | 1 week after the 3-week period ends, interview conducted over the phone or at a clinic visit. |
|
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D011634 | Public Health |
| D004778 | Environment and Public Health |